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Facial expression recognition as a
candidate marker for autism spectrum
disorder: how frequent and severe are
deficits?
E. Loth1,2* , L. Garrido3, J. Ahmad2, E. Watson2, A. Duff2 and B. Duchaine4
Abstract
Background: Impairments in social communication are a core feature of Autism Spectrum Disorder (ASD). Because
the ability to infer other people’s emotions from their facial expressions is critical for many aspects of social
communication, deficits in expression recognition are a plausible candidate marker for ASD. However, previous
studies on facial expression recognition produced mixed results, which may be due to differences in the sensitivity
of the many tests used and/or the heterogeneity among individuals with ASD. To ascertain whether expression
recognition may serve as a diagnostic marker (which distinguishes people with ASD from a comparison group) or a
stratification marker (which helps to divide ASD into more homogeneous subgroups), a crucial first step is to move
beyond identification of mean group differences and to better understand the frequency and severity of
impairments.
Methods: This study tested 46 individuals with ASD and 52 age- and IQ-matched typically developing (TD)
participants on the Films Expression Task, which combines three key features of real-life expression recognition:
naturalistic facial expressions, a broad range of simple and complex emotions, and short presentation time. Test-
retest reliability was assessed in 28 individuals who did not participate in the main study and revealed acceptable
reliability (ICC r = .74).
Results: Case-control comparisons showed highly significant mean group differences for accuracy (p = 1.1 × 10− 10),
with an effect size (Cohen’s d = 1.6), more than twice as large as the mean effect size reported in a previous meta-
analysis (Uljarevic and Hamilton, 2012, J Autism Dev Disord). The ASD group also had significantly increased mean
reaction times overall (p = .00015, d = .83) and on correct trials (p = .0002, d = .78). However, whereas 63% of people
with ASD showed severe deficits (they performed below two standard deviations of the TD mean, a small
subgroup (15.3%) performed normally (within one standard deviation of the mean).
Conclusion: These findings indicate that the majority of people with ASD have severe expression recognition
deficits and that the Films Expression Test is a sensitive task for biomarker research in ASD. Future work is needed
to establish whether ASD subgroups with and without expression recognition deficits differ from one another in
terms of their symptom profile or neurobiological underpinnings.
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Background
Autism spectrum disorder (ASD) is a life-long neurodeve-
lopmental disorder, behaviourally defined by impairments
in social communication and the presence of repetitive
and restricted behaviours and interests [1]. The consider-
able variability in the quality and severity of symptoms
between individuals with ASD is widely recognized [2].
For example, social communicative impairments can be
manifested in a range of difficulties in social-emotional
reciprocity, in non-verbal communicative behaviours, and
in developing and maintaining social relationships [1].
Recognition of this heterogeneity has begun to cast doubt
as to whether a truly diagnostic biological or behavioural
marker for ASD exists (which differentiates all or the
majority of people with ASD from typically developing
individuals or those with other neurodevelopmental/psy-
chiatric conditions) and prompted an increasing interest
in the identification of stratification markers to parse ASD
into more homogeneous subgroups [3]. Biomarkers
have been defined as “a characteristic that is object-
ively measured and evaluated as an indication of
normal biological processes, pathogenic processes, or
pharmacologic responses to a therapeutic interven-
tion” [4]. Here we use the term “biomarker” in a broad
sense to refer to measures of any modality, including
cognitive/behavioural tests [4]. Stratification bio-
markers are then characteristics that vary between
ASD subgroups and that map onto differences in their
symptom presentation, etiology, need for particular
treatments, and/or treatment response.
Because the ability to infer other people’s emotions from
their facial expressions is critical for many aspects of social
communication, deficits in expression recognition have
long been suggested to represent a core impairment in
ASD [5]. However, over the past three decades, behav-
ioural studies of facial expression recognition in ASD have
produced mixed findings, ranging from reports of pro-
found deficits to apparently intact expression recognition
skills (see e.g., [6, 7] for recent reviews). A review of this
literature suggests that in ASD, the presence and severity
of expression recognition deficits on experimental tests is
influenced by both participant characteristics—age and
ability level—and task requirements [7]. On the whole,
deficits in recognizing basic emotion expressions ap-
pear to be predominantly found in children and low-
functioning individuals (i.e., people with ASD who also
have intellectual disabilities) [5, 8]. By contrast, high-
functioning individuals with ASD (with IQ in the normal
range) usually perform well on tests that depict facial ex-
pressions in a prototypical manner and that used relatively
long presentation times [9–11]. However, some studies
reported group-level deficits in recognizing expressions of
complex emotions (e.g., guilt, defiance) [9, 12], expressions
that were presented only briefly [13] or subtle expressions
displayed with low intensities [14] using morphs [15, 16].
Furthermore, speed-accuracy trade-offs [17], abnormal
gaze fixation patterns [18], and differences in underlying
neural processes as measured by EEG [19] and fMRI have
also been reported [20, 21]. However, some inconsisten-
cies remain even within the different methodologies and
sample types. For example, some studies have found mean
group deficits in adult ASD samples with IQ in the normal
range on tasks that required labeling basic emotions with
unlimited presentation times [20, 22, 23], while others
reported no deficits in the recognition of complex
emotions [24].
Recently, a formal meta-analysis of 48 papers con-
cluded that there is an emotion recognition difficulty in
“autism”, with a mean effect size of Cohen’s D = 0.80, yet
this was estimated to decrease to around 0.40 after
adjusting for publication biases [6]. Hence, it remains
unclear whether differences in study findings reflect
variability in the nature or sensitivity of the many behav-
ioural tests used to assess expression recognition in ASD
and/or differences in the severity of deficits among people
with ASD.
To ascertain the value of expression recognition defi-
cits as a candidate diagnostic or stratification biomarker
we need, first, sensitive tests that incorporate several
real-life characteristics. For example, in daily life, facial
expressions are usually more subtly displayed than those
depicted in most standard stimuli of “prototypical” facial
emotion expressions. People also often reveal their emo-
tions for only a very brief time. The observer is then re-
quired to identify the facial emotion expression quickly
to react appropriately to the person’s feelings. Second,
the field needs to move away from a sole focus on mean
between-group differences to better understand the fre-
quency and severity of expression recognition deficits
among individuals with ASD. For example, in case-
control studies, a significant p value (especially in com-
bination with small or medium effect sizes) could either
reflect (small) deficits in most cases (say, around 1 SD
below the typically developing (TD) mean) or may be
driven by a subgroup of individuals with severe deficits.
Obviously these two scenarios have profoundly different
implications for the potential utility of the test in clinical
practice.
Hence, the aim of this study was to investigate the
frequency and severity of deficits in the recognition of
facial expressions of emotion using a task that is more
sensitive and naturalistic than previous tests. The
Films Expression Task [25] uses still images captured
from movie scenes and combines three elements that
appear to be challenging for people with ASD: depic-
tion of naturalistic facial expressions, inclusion of a
range of both basic and complex emotions, and brief
presentation times.
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Methods
The Films Expression Task
The Films Expression Task [25] consists of 58 trials. In
each trial, participants were first presented with an ad-
jective describing an emotional state (e.g., confident,
pleased). They were then briefly shown three images one
after the other (500 ms each, with a 500 ms blank screen
between images). The images were taken from films
made in non-English-speaking countries to decrease the
probability that participants had seen them or were
familiar with the actors.
Within each trial, images present the same actor or
actress, but with different emotional expressions. Partici-
pants were asked to indicate, by key press, which of the
images best matched the target word. In 14 trials, the
target emotion was a basic emotion (happy, angry, sad,
afraid, surprised, disgusted). In the remaining 44 trials,
the target emotion was complex (e.g., mocking, hurt,
disappointed, resentful, see Additional file 1 for the list
of target emotions). In trials with both basic and com-
plex target emotions, the foils were selected to be similar
to the targets in terms of perceptual features and inten-
sity of the expression (see supplementary information
[25]). Basic vs. complex emotion trials were presented
interleaved, in a fixed-random order. Participants were
instructed to respond as quickly and accurately as
possible.
Immediately before the task, participants were pre-
sented with the definitions for each word describing a
target emotion (e.g., guilty). They were encouraged to
ask questions if they were unfamiliar with or did not
understand any of the words. Participants were also
allowed to review these definitions at the start of each
trial, after presentation of the target word.
Task development and validation of the stimuli is
described in [25] (supplementary information). Briefly,
in pilot phase 1, three researchers suggested adjectives
to describe 122 pictures of facial expressions taken from
18 films. In pilot phase 2, 32 native English speakers
rated how well each adjective described the facial ex-
pression on a scale from 1 to 5 (1 = “it doesn’t match at
all”, 5 = “it matches very well”). Adjectives were only
carried forward if they had received at least a mean
rating of 3.5 or a median rating of at least 4. Ten of
these participants then also rated the intensity of the
target expression from 1 to 5 (1 = “not intense” to 5 =
“very intense”) as well as the intensity of the expressions
intended as foils. Targets and foils were then matched
based on their expression intensity. In pilot phase 3, 30
different native English speakers were asked to choose
one of two simultaneously presented expressions (the
target and a foil) that best matched an adjective. Distrac-
tors were only included if participants had selected them
less than 30% of the time. A fourth final pilot phase
included ten new participants and employed the
intended task procedure in which three pictures were
presented sequentially, one target and two distractors.
Only trials with equal or less than 30% errors were
carried forward, which resulted in 58 trials with tar-
gets taken from 15 films.
IQ measures
Verbal, performance, and full-scale IQ were assessed
using the Wechsler Abbreviated Scale of Intelligence-
2nd edition (WASI-II; Wechsler, [26]) or a four-subtest
short-form of the Wechsler Adult Intelligence Scale-
Third Edition (WAIS-III; [27]). In both instances, the tests
included two verbal subscales (vocabulary, similarities)
and two non-verbal subscales (block design, matrix rea-
soning). Standardized scores from the WASI-II and WAIS
are comparable.
Autism Spectrum Quotient
The Autism Spectrum Quotient (AQ) [28] is a self-
report questionnaire to assess whether adults of
average intelligence have symptoms associated with
autism spectrum disorder. The test consists of 50
statements and participants indicate whether they
“definitely agree”, “slightly agree”, “slightly disagree”,
or “definitely disagree” with each statement. Approxi-
mately half the items are worded to usually elicit an
“agree” response from neurotypical individuals and
half to usually elicit a “disagree” response. The ques-
tions cover five different domains associated with the
autism spectrum: social skills, communication skills,
imagination, attention to detail, and attention switching/
tolerance of change.
Test-retest reliability of the films expression test
Thirty-one participants took part in a test-retest study to
assess the reliability of the Films Expression Test. We
aimed to recruit participants with a range of expression
recognition abilities to ensure that test-retest reliability
on this task was stable at both high and low perform-
ance scores. Because we hypothesized that individuals
with ASD would have lower accuracy scores than typically
developing individuals, four participants were recruited
from an autism support group. Hence, 27 participants
were typically developing, three had a formal diagnosis of
autism, and one was suspected of having autism.
Two participants exceeded the intended maximum re-
test interval of 6 weeks and did not complete the retest,
one participant’s retest data was not available after a
technical error. This left 28 participants (20 females and
8 males, mean age = 33.48 years; range = 20–57 years,
four from the autism support group). Out of the 28
participants, English was a second language for six but
all participants described themselves as fluent English
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speakers. The retest interval ranged from 14 to 34 days,
with an average interval of 18.11 days.
All test-retest participants also completed a two-subtest
(vocabulary and matrix reasoning) short-form of the
Wechsler Abbreviated Scale of Intelligence (WASI-II;
[26]). The mean two-scale IQ was 113.07 (range 87–146).
Test-retest analysis revealed an intra-class correl-
ation coefficient of ICC = .74, indicating acceptable
reliability. The mean accuracy score at time 1 was
86.64% (SD = 7.49, range 62.07–98.28%) and at time 2
was also 86.64% (SD = 7.93, range 62.07–94.83%). Indi-
vidual difference scores, calculated between time 1
and time 2 performance, showed that 17 (60.71%) par-
ticipants had a difference score less than .5 SDs, 6
(21.43%) were between .5 and 1 SD, and 5 were
(17.86%) greater than 1 SD.
Participants
In the main study, participants consisted of 46 adoles-
cents or adults with ASD (34 male, 12 female) and 53
typically developing (TD) individuals (33 male, 20
female). Eighteen TD participants were tested as part of
a previous study [25]. Although the ASD group included
a higher proportion of males than the TD group, the dif-
ference in the sex ratio between the groups was not sta-
tistically significant (χ2 = 1.5, p = .21). Mean age of the
ASD group was 30.2 years (SD 9.4, 15–50 years) and of
the TD group was 27.5 years (SD 7.8, range 14–55 years).
Two participants in the ASD group (15 and 17 years)
and two participants in the TD group (15 and 14 years)
were younger than 18 years. IQ data was available for 42
out of 46 participants with ASD and all participants in the
TD group. Mean verbal and full-scale IQ in the ASD group
were 113.9 (range 85–140) and 116.0 (range 87–135), re-
spectively, and in the TD group were 114.0 (range 74–146)
and 115.5 (range 85–143). The groups did not significantly
differ from each other in terms of age (t(86) = 2.3, p = .12),
full-scale IQ (t(86) = .02, p = .87), verbal IQ (t(86) = .0004,
p = .98), or performance IQ (t(86) = .002, p = .96). The four
individuals with ASD for whom no IQ data were available
had attended mainstream schools, which suggests that
their IQ was within the normal range.
All participants with ASD except one were native
English speakers. In the TD group, 37 of 53 participants
were native English speakers. All TD participants for
whom English was not their first language described
their current English language level as “fluent”. Fourteen
individuals performed within 1 SD of the TD mean or
above, one individual below 1 SD, and two individual
below 2 SDs of the TD mean. Of these two TD partici-
pants, one had an above-average verbal IQ (VIQ) (124),
indicative of adequate language comprehension and was
therefore not excluded. The other TD participant had an
accuracy score of more than 4 SDs below the TD mean
(male, 32 years, VIQ = 92, first language Uzbek) and was
excluded from the analyses reported below. This left 46
people with ASD and 52 people with TD. The study was
approved by the South London and Maudsley NHS
Trust ethics committee and the UCL Research Ethics
Committee. All participants or a parent in the case of
participants who were minors gave informed written
consent before study participation.
Results
Case-control comparisons
Descriptive statistics are provided in Additional file 2.
The ASD group accurately identified an average of
70.8% (SD = 13.5) of the briefly presented emotion ex-
pressions, compared to 87.5% (SD = 5.5) in the control
group (see Fig. 1a). The Welch test, which does not
assume equal variances, showed that this mean group
difference was highly significant (t(58.1) = − 7.8, p =
1.1 × 10−10). The effect size (Cohen’s d) was 1.62. We
used bootstrapping in Matlab version 8.3.0.532 (Math-
works, Natick, MA) to estimate the 95% confidence interval
around this point estimate. We drew 10,000 resamples
from the original sample using random sampling with
replacement. We obtained a distribution of effect sizes for
all the resamples, and using the percentile method (i.e.
using the 2.5 and 97.5 percentiles as lower and upper
bounds of the CI), the 95% CI was [1.30 2.05].
Analyses of reaction times (RT) revealed that the
ASD group also responded significantly more slowly
(M = 1459 ms, SD = 899) than the TD group (M = 878 ms,
SD = 414) across all trials (t(61.5) = 4.02, p = .00015,
Cohen’s d = .83, 95% CI [0.49 1.19]) as well as on their cor-
rect trials (ASD: M = 1279 ms, SD = 812; TD: M = 767 ms,
SD = 352) (t(df = 59.7) = 3.96, p = .0002, Cohen’s d = 0.82,
95% CI [0.49 1.17]). These findings remain unchanged
when adolescents below the age of 18 years were excluded
(accuracy: ASD = 70.2%, TD = 87.7%; t(53.5) = 7.9, p =
1.4 × 10−10) (see Fig. 1b).
Sex differences
Given previous reports of sex differences on several
social-cognitive tasks in the typical population and in
ASD [29], we performed 2 (group) × 2 (sex) ANOVAs to
test whether accuracy, overall RT, or RT on correct trials
differed between males and females overall or in either
group. These tests confirmed the significant effects of
group on accuracy (F(1,97) = 65.0, p = 2.3 × 10−12) and
RTs (all ps < .00007) but there were no significant effects
of sex (all ps > .5)) or group by sex interactions (all ps >
.11). This finding indicates that the overall case-control
difference cannot be attributed to differences in the
slightly higher male:female ratio in the ASD than those
in the control group.
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Basic vs. complex emotions
Next, we explored whether in the ASD group, the ex-
pression recognition impairments reported above were
driven by specific problems in identifying complex
emotional expressions. To do so, we separately ana-
lysed trials with simple vs. complex target emotions
(see Additional file 1).
A 2 (group) × 2 (emotion category) repeated-measures
ANOVA revealed the above reported significant main ef-
fect of group (F(1,96) = 70.7, p = 3.8 × 10−13) and a signifi-
cant effect of emotion category (F(1,96) = 5.9, p = .016) on
response accuracy, such that on average, both groups were
better at recognizing simple than complex emotions. The
group x emotion category interaction was not significant
F(1,96) = .14, p = .7) (see Fig. 2).
Correlations between accuracy and RT scores with age
and IQ
Next, we tested whether age, verbal, performance, or full-
scale IQ were related to accuracy or reaction time (RT
overall or on correct trials) on the Films Expressions Test.
In the ASD group, we found no significant relationships
between expression recognition variables and age or IQ
(all p > .09). In the TD group, there was a marginally
significant relationship between accuracy scores and FIQ
(r(52) = .26, p = .057), such that participants with higher
intelligence also had higher expression recognition
scores.
Frequency and severity of expression recognition deficits
in ASD
To establish the frequency and severity of expression
recognition deficits in the ASD group, we calculated
how far the accuracy score for each individual with ASD
deviated from the TD group mean. Analyses of the
scores showed that 63% of people with ASD performed
more than 2 SDs below the TD mean. Of those, 23.9%
performed between 2 and 3 SDs below the TD mean
and 39.1% performed more than 3 SDs below the TD
mean (see Fig. 3). 21.7% of people with ASD performed
between 1 to 2 SDs below the TD mean while 15.3% had
accuracy scores within the TD range. The 17-year-old
with ASD performed within the 1 SD of the TD range,
while the 15-year-old with ASD performed between 2
and 3 SDs below the TD range. As shown in Fig. 4, in
the ASD group, accuracy and RT scores were negatively
correlated such that individuals with ASD who had
higher accuracy scores were also able to correctly
recognize the emotion faster than those with low accur-
acy scores. Therefore, there was no evidence of speed-
accuracy trade-off for most of the ASD participants who
performed accurately on the task. These results suggest
that the majority (63%) of individuals with ASD had
severe deficits, while a small subgroup of around 15% of
people with ASD showed intact expression recognition
skills on this test.
Correlations between accuracy and RT scores and ASD
symptoms
Finally, we investigated correlations with ASD symptoms
in a subset of N = 53 participants (ASD = 25, TD = 28) for
whom AQ data was available (see Fig. 5). When both
groups were collapsed, we found a significant negative
Fig. 1 a Accuracy: percentage of correct trials, by group. b Mean reaction time of correct trials and mean reaction time overall, by group
Fig. 2 Percentage of correct trials, by emotion category and group
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correlation between the percentage of correct responses
on the Films Expression Task and higher ASD symptoms
r(53) = − .48, p = .0002. However, when the ASD and TD
groups were considered separately, there were no signifi-
cant relationships in either group (ASD r(25) = .09, p = .66,
TD r(28) = .03, p = .88). This suggests that the negative
correlation for the overall sample could be explained by
the performance differences between the two groups.
A somewhat different picture emerged for RTs. We
found that longer reaction times on correct trials were
associated with more ASD symptoms. This was signifi-
cant overall, i.e., when both groups were collapsed
(RTcorrect trials: overall r(53) = .53, p = .00003) and in the
TD group (TD r(28) = .48, p = .012). Although a similar
pattern was found in the ASD group, it did not reach
statistical significance (ASD r(25) = .29, p = .16).
Likewise, for overall RTs, we found a significant rela-
tionship with ASD symptoms when both groups were
collapsed (RToverall: overall: r(53) = .54, p = .000026).
When the TD and ASD groups were analysed separately,
similar but non-significant patterns were found (TD:
r(28) = .31, p = .10, ASD: (r(25) = .29, p = .16).
Discussion
This study investigated the frequency and severity of im-
pairments in facial expression recognition in ASD using
a test that captured several features of expression recog-
nition in daily life. A test-retest study showed reliability
of .74, which is considered adequate for a test to be of
use in clinical settings [30, 31]. At the group level, we
found highly significant differences in accuracy and re-
sponse times between a group of high-functioning adults
and adolescents with ASD and an age- and IQ-matched
TD control group. Effect sizes of the accuracy scores
were more than twice as large as those estimated in a re-
cent meta-analysis of studies on emotion recognition in
ASD and more than four times larger than estimates
that accounted for publication biases [6].
As a first step towards ascertaining whether deficits in
expression recognition may serve as a diagnostic or
stratification marker for ASD, we investigated the fre-
quency and severity of these deficits. This revealed that
63% of people with ASD had severe deficits, which
would be expected to create substantial social communi-
cative difficulties. For example, participants who per-
formed below 3 SDs of the TD mean failed to identify
the briefly displayed target emotion expression in 3–7
out of 10 trials. Translated into real-life settings, it is
Fig. 4 Scatterplot showing percentage of accuracy and RT on
correct trials, by group. Grey bars denote − 2to + 2 SDs of the TD
means on percentage of correct expression recognition
Fig. 3 Upper panel: Distribution of TD performance on percentage of accuracy. Lower panel: Distribution ofASD performance on percentage of
accuracy. Grey bars denote − 2 to + 2 SDs of the TD means on percentage of correct expression recognition
Loth et al. Molecular Autism  (2018) 9:7 Page 6 of 11
easy to see how this may impact the ability to, for ex-
ample, modulate a conversation or to respond empathic-
ally [32]. However, we also found considerable variability
in that 21.7% performed between 1 to 2 SDs below the
TD mean and 15.3% evidenced expression recognition
skills indistinguishable from TD individuals (within 1 SD
of the TD mean) as indexed by the combination of both
accuracy and RT scores. This variability in expression
recognition skills among individuals with ASD was unre-
lated to age or IQ (verbal or non-verbal). However, it
should be borne in mind that the IQ range in the
current sample was restricted to the normal range, so
that this finding may not generalize to individuals with
ASD and intellectual disabilities.
The present findings are broadly consistent with other re-
cent efforts to parse heterogeneity in ASD. In particular,
Lombardo and colleagues [33] used unsupervised hierarch-
ical clustering approaches to identify ASD subgroups on
the basis of item-level performance on the Reading the
Mind in the Eyes Test (RMET).The RMET is a widely used
mentalising task that also involves a strong emotion recog-
nition component [34] as it requires participants to identify
the mental or emotional state of a person from their eye re-
gion only. The study (which comprised a discovery and
replication cohort) identified five ASD subgroups and four
TD subgroups. For individuals with ASD, 45–62% showed
what the authors termed “clear to immediate impairments”,
while two subgroups (19–36%) performed more than 2 and
up to 11 SDs below the TD means - depending on the TD
subgroup that was used as comparison. It would be valu-
able for future studies to directly compare performance on
the RMET and Films Expression Tasks or combine infor-
mation from both measures to derive a composite score.
A second requirement for a quantitative stratification
marker is to demonstrate clinical relevance, for example,
that people who fall within a certain range of deficits differ
from those without abnormalities (normal range) in terms
of symptom severity. To begin to address this, we con-
ducted correlation analyses between severity of expression
recognition deficits and ASD symptom severity, as mea-
sured by the AQ. When the ASD and TD groups were
combined, we found both lower accuracy in expression rec-
ognition and higher RTs to be moderately related to greater
severity of autism traits. However, whereas accuracy scores
were not sensitive to the severity of ASD symptoms within
the ASD and TD groups, respectively, longer reaction times
on correct trials were significantly related to greater ASD
symptoms in the TD group. A similar relationship was
found in the ASD group with moderate correlation coeffi-
cients which, however, did not reach statistical significance.
These correlation analyses should be viewed as preliminary,
because AQ scores were only available in about half of the
participants. As a consequence, the sample sizes were small
when split by group, which reduced our power to detect a
significant effect. In addition, the AQ is a composite meas-
ure of a range of autism-related traits, including features
such as intolerance of changes that may not be expected to
relate to expression recognition. This may have diluted po-
tentially higher associations with more specific social com-
municative impairments.
In sum, our findings revealed that the majority of
individuals with ASD had severe deficits in expression
recognition deficits but also that a sub-sample of indi-
viduals with ASD had no behavioural impairments on
this task. This indicates that expression recognition may
more likely serve as a stratification as opposed to diag-
nostic marker, subject to further substantiation that sub-
groups with/without expression recognition deficits also
differ in symptom severity or adaptive behavior. One
implication of the current findings is that intervention
programmes that specifically target expression recogni-
tion may be valuable for a substantial proportion of
people with this disorder.
Study limitations and future directions
Several potential limitations of the current study as well
as implications for future research should be considered.
First, we deliberately chose a task that incorporated
Fig. 5 Scatterplot showing the relationship between AQ scores and a accuracy scores, b overall RTs, and c RTs for correct responses. Regression
lines are plotted overall, and for the ASD and TD groups separately. Grey bars denote − 2 to + 2 SDs of the TD means on percentage of correct
expression recognition, RTs, and RTs on correct trials
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several factors crucial for expression recognition in real-
life situations, including a wide range of simple and
complex target emotions, and relatively short presenta-
tion times. As a consequence, could factors unrelated to
expression recognition per se have contributed to the
deficits observed in some of the ASD participants, for
example, comprehension of the target words or other
cognitive impairments/ anomalies?
If difficulties in comprehending some of the emotion
words accounted for performance impairments, one
would expect larger group differences in trials with
complex target emotions than basic emotions. However,
separate analyses, split by emotion target (simple vs com-
plex), showed significant impairments in the ASD group
on trials with basic as well as complex emotions. Basic
emotion words are typically understood by the age of
6 years or earlier. Also most of the complex emotions
used here are typically understood by age 8 (see Add-
itional file 1), and the ASD participants had verbal
IQs within (and mostly above) the population average.
However, recognition of complex emotions also re-
quires an understanding of the mental states they de-
scribe [34] and some high-functioning individuals
with ASD may also have deficits in theory of mind
[35]. Therefore, future studies should probe compre-
hension of the different emotion words and account
for individual differences in understanding particular
words and their emotional state—independent from
recognition of their manifestation in facial
expressions.
Previous studies reported that expression recognition
deficits varied with the type of emotion, such that recog-
nition of fear has been found to be more impaired than
happiness (see [6] for a review). The naturalistic charac-
ter of the task did not enable us to systematically analyse
recognition of different types of emotion expressions
(fear, anger, disappointment, etc.) as 34 different emotion
adjectives were included, and many of the target emo-
tions were only used once. However, descriptive trial-by-
trial analyses, split by group (see Fig. 6) suggest that the
mean percentages of correct response not only varied be-
tween target emotions but in some instances also within
target emotions. For example, among the ASD group
“angry” and “happy” trials had the highest percentages of
correct responses whereas trials with the target emotions
“disappointed”, “tentative”, and “disbelieving” had the
Fig. 6 Percentage of correct responses, by trial. a ASD group. b TD group
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lowest percentages. For “sad” trials, correct recognition
ranged from 56.5 to 73.9%. The latter finding may be due
to the fact that the difficulty level of a trial is influenced by
the nature of the target emotion and also by the expres-
sions in the distractor stimuli used in a trial.
Could more general problems in rapid visual process-
ing have contributed to deficits in recognizing relatively
briefly presented (500 ms) facial expressions of emo-
tions? This alternative explanation seems unlikely for
two reasons. Several previous studies reported no defi-
cits in rapid visual processing in ASD [13, 36]. For
example, a study that tested recognition of micro-facial
expressions, using much faster presentation times (15
and 30 ms) than those employed here reported specific
deficits in identifying facial expressions, but not objects
in an ASD group [37]. Moreover, as indicated above, our
trial-by-trial analyses (see Fig. 6) showed quite variable
performance scores between trials in the ASD group,
with two trials being correctly identified by over 90% of
the ASD participants. This pattern of largely intact ex-
pression recognition on some trials but impairments on
others would be inconsistent with general problems in
rapid visual processing. However, it remains a possibility
that other cognitive abnormalities previously reported in
(some people with) ASD, such as a detail-focused pro-
cessing style [38] abnormalities in top-down processing
[39] or difficulties with other aspects of face perception
[40], may have contributed to behavioural impairments
in expression recognition.
The present finding raises the question of what may ac-
count for the differences between people with ASD with/
without expression recognition deficits. This question can-
not be settled here but we discuss potential factors and
outline some avenues for future research. A likely possibil-
ity is that (some) people with ASD have problems in the
neurocognitive mechanisms that represent facial expres-
sion information and/or multi-modal expression informa-
tion. One hypothesis that recently gained prominence is
the notion that expression recognition deficits in ASD
may be linked to the high frequency of comorbid alexithy-
mia [41, 42], estimated to affect around 50% of people
with ASD [43, 44]. Alexithymia is a sub-clinical trait char-
acterized by difficulties in identifying and describing one’s
own emotional state [45]. Future work—ideally with larger
samples—will be needed to ascertain whether some or all
individuals with ASD who exhibit substantial expression
recognition deficits also have higher rates of trait alexithy-
mia. Other potential underlying mechanisms may include
differences in attention (e.g., to the eye region [11, 46]), or
brain structural/functional anomalies [20]. To identify the
factors that underpin expression recognition impairments
at an individual level will require multi-modal studies
and/or designs that assess a range of cognitive functions
within each individual. We have included an abridged
version of the Films Expression Test and a companion
child version in the follow-up assessment battery of the
EU-AIMS Longitudinal European Autism Project [47, 48]
to test whether the current findings can be replicated in
an independent sample more diverse in age and ability
level, to further determine the clinical usefulness of our
findings, and to investigate potential underlying
mechanisms.
Conclusion
Taken together, our findings show highly significant
mean case-control differences in facial expression
recognition, with one of the largest effect sizes ever
reported in the expression recognition literature of
ASD. This suggests that problems with expression rec-
ognition are more widespread than currently thought,
likely owing to the more naturalistic character of the
tasks used here. Nevertheless, we also highlight im-
portant variability in expression recognition skills
among individuals with this condition and showed
that a minority of people with ASD had no behav-
ioural impairments. This finding indicates that the
Films Expression Test may serve as a valuable tool to
study expression recognition as a candidate stratifica-
tion marker for ASD.
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